Recently, EIF4A3 was recognized as a putative oncogene, leading to an increase in the studies determining its role in cancer development (Kanellis et al., 2021; Wang et al., 2020; Wang et al., 2021b; Zheng et al., 2020). This evidence concerns the gene EIF4A3 and cancer.